Patents Assigned to Purple Biosciences LLC
  • Publication number: 20230051702
    Abstract: A composition for mitigating, treating, and/or preventing symptoms associated with veisalgia. In one embodiment the composition comprises one or more ingredients selected from the group consisting of: dihydromyricetin, N-acetyl cysteine, salicin, quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, monk fruit, turmeric, curcumin, ginger root, and black pepper extract. A method for treating symptoms associated with veisalgia is also described. In one embodiment, the composition is administered in liquid or pill form.
    Type: Application
    Filed: October 31, 2022
    Publication date: February 16, 2023
    Applicant: Purple Biosciences LLC
    Inventor: Monir Elias
  • Patent number: 11484523
    Abstract: A composition for mitigating, treating, and/or preventing symptoms associated with veisalgia. In one embodiment the composition comprises one or more ingredients selected from the group consisting of: dihydromyricetin, N-acetyl cysteine, salicin, quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, monk fruit, turmeric, curcumin, ginger root, and black pepper extract. A method for treating symptoms associated with veisalgia is also described. In one embodiment, the composition is administered in liquid or pill form.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: November 1, 2022
    Assignee: Purple Biosciences LLC
    Inventor: Monir Elias